Latiglutenase Improves Symptoms in Seropositive Celiac Disease Patients While on a Gluten-Free Diet

被引:0
作者
Jack A. Syage
Joseph A. Murray
Peter H. R. Green
Chaitan Khosla
机构
[1] ImmunogenX,Division of Gastroenterology and Hepatology
[2] Mayo Clinic,Departments of Chemical Engineering and Chemistry
[3] Celiac Disease Center at Columbia University,undefined
[4] Stanford University,undefined
来源
Digestive Diseases and Sciences | 2017年 / 62卷
关键词
Celiac disease; Latiglutenase; Therapy; Symptoms;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2428 / 2432
页数:4
相关论文
共 59 条
[1]  
Rubio-Tapia A(2010)Celiac disease Curr Opin Gastroenterol 26 116-122
[2]  
Murray JA(2013)Interest in medical therapy for celiac disease Ther Adv Gastroenterol 6 358-364
[3]  
Tennyson CA(2011)Are patients with coeliac disease seeking alternative therapies to a gluten-free diet? J Gastrointestin Liver Dis 20 27-31
[4]  
Simpson S(2015)Development of drugs for celiac disease: review of endpoints for phase 2 and 3 trials Gastroenterol Rep (Oxf) 3 91-102
[5]  
Lebwohl B(2014)Glutenase alv003 attenuates gluten-induced mucosal injury in patients with celiac disease Gastroenterology 146 1649-1658
[6]  
Lewis S(2015)Engineering of kuma030: a gliadin peptidase that rapidly degrades immunogenic gliadin peptides in gastric conditions J Am Chem Soc 137 13106-13113
[7]  
Green PH(2015)Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial Gastroenterology 148 1311-1319
[8]  
Aziz I(2007)Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue Gastroenterology 133 472-480
[9]  
Evans KE(2007)A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease Am J Clin Nutr 85 160-166
[10]  
Papageorgiou V(2017)No difference between latiglutenase and placebo in reducing villous atrophy or improving symptoms in patients with symptomatic celiac disease Gastroenterology 152 787-798